Tag: biopharma
DBT & BIRAC announce a joint call for proposals on Bio-AI...
Bio-AI hubs are proposed to be established across academia and industry to provide critical and novel research leads
BioVoice eMagazine May 2025 | Issue 5 | Volume 6
The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.
Zydus Lifesciences completes 25 years of listing on NSE, commemorated with...
Over the last 24 years, the Company's sales has grown from Rs 478 crores to Rs 19,022 crores, a CAGR of 17%
Cadila Pharma marks three years of ThRabis, world’s first three-dose rabies...
ThRabis® was launched in April 2022 and has since been rolled out in multiple countries, offering a simpler, shorter vaccination schedule
Experts discuss IP & tech transfer best practices at World IP...
The event was supported by the National Biopharma Mission, BIRAC, and Institution’s Innovation Council (IIC)
Leucine Rich Bio to host second edition of ‘World of Microbiome’
In the spirit of Health Month, Leucine Rich Bio sparks the only Indian platform dedicated exclusively to the future of gut health and microbiome science
BioVoice eMagazine April 2025 | Issue 4 | Volume 6
The Cover Story analyzes the blockbuster opportunity for India's biopharma industry. Read interviews of Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited; Sachin Joshi, MD & Founder, PharmNXT Biotech; Mandeep Singh Kumar, MD and Vice President, Medtronic India; and Harshvardhan Bhagchandka, President, IPL Biologicals
Avantor recognized with two prestigious awards at Asia-Pacific Biopharma Excellence Awards...
Awards highlight Avantor's commitment to the biopharma industry
Home Minister Amit Shah applauds Arjun Deshpande for revolutionizing affordable healthcare...
The recognition marks a significant milestone in 22 year old entrepreneur's journey to revolutionize the pharmaceutical industry and ensure that quality healthcare reaches every Indian at significantly reduced costs
Cell & gene therapy market set to grow at 44% CAGR...
Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData